| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
153,922,000 |
| Market
Cap: |
6.15(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$36.9 - $39.95 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile IVERIC bio is biopharmaceutical company focused on the discovery and development of treatments for retinal diseases with unmet medical needs. Co.'s clinical stage product candidate, Zimura® (avacincaptad pegol), a complement C5 inhibitor. Co. is targeting the following diseases with Zimura: Geographic Atrophy, intermediate age-related macular degeneration, and autosomal recessive Stargardt disease. In addition to Zimura, Co. is developing its preclinical product candidate IC-500, a high temperature requirement A serine peptidase 1 protein inhibitor, for GA and potentially other age-related retinal diseases.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
40,000 |
561,286 |
| Total Sell Value |
$0 |
$0 |
$1,546,400 |
$15,378,126 |
| Total People Sold |
0 |
0 |
1 |
5 |
| Total Sell Transactions |
0 |
0 |
2 |
30 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Versant Ventures Iv, Llc |
10% Owner |
– – • |
2019-01-14 |
4 |
A |
$2.30 |
$300,001 |
I/I |
130,526 |
32,394 |
|
- |
|
| Westby Keith |
SVP & COO |
• – – |
2019-01-07 |
4 |
S |
$1.30 |
$389 |
D/D |
(299) |
32,606 |
|
- |
|
| Guyer David R |
Executive Chairman |
• • – |
2019-01-07 |
4 |
S |
$1.30 |
$5,017 |
D/D |
(3,859) |
43,164 |
|
- |
|
| Westby Keith |
SVP & COO |
• – – |
2019-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
700 |
32,905 |
|
- |
|
| Guyer David R |
Executive Chairman |
• • – |
2019-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,250 |
47,023 |
|
- |
|
| Guyer David R |
Executive Chairman |
• • – |
2019-01-03 |
4 |
S |
$1.24 |
$4,510 |
D/D |
(3,637) |
40,773 |
|
- |
|
| Westby Keith |
SVP & COO |
• – – |
2019-01-03 |
4 |
S |
$1.24 |
$424 |
D/D |
(342) |
32,205 |
|
- |
|
| Guyer David R |
Executive Chairman |
• • – |
2019-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,750 |
44,410 |
|
- |
|
| Westby Keith |
SVP & COO |
• – – |
2019-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
781 |
32,547 |
|
- |
|
| Carroll David Francis |
SVP, CFO and Treasurer |
• – – |
2018-07-02 |
4 |
S |
$2.68 |
$7,332 |
D/D |
(2,736) |
8,980 |
|
- |
|
| Carroll David Francis |
SVP, CFO and Treasurer |
• – – |
2018-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
11,716 |
|
- |
|
| Sblendorio Glenn |
President and CEO |
• – – |
2018-04-02 |
4 |
S |
$2.69 |
$18,394 |
D/D |
(6,838) |
48,407 |
|
- |
|
| Sblendorio Glenn |
President and CEO |
• – – |
2018-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,750 |
55,245 |
|
- |
|
| Guyer David R |
Executive Chairman |
• • – |
2018-01-05 |
4 |
S |
$3.17 |
$12,040 |
D/D |
(3,798) |
38,660 |
|
- |
|
| Westby Keith |
SVP & COO |
• – – |
2018-01-05 |
4 |
S |
$3.17 |
$1,005 |
D/D |
(317) |
24,983 |
|
- |
|
| Wood Barbara A |
SVP, Gen. Counsel, Secretary |
• – – |
2018-01-05 |
4 |
S |
$3.17 |
$1,908 |
D/D |
(602) |
16,462 |
|
- |
|
| Guyer David R |
Executive Chairman |
• • – |
2018-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,250 |
42,458 |
|
- |
|
| Westby Keith |
SVP & COO |
• – – |
2018-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
700 |
25,300 |
|
- |
|
| Wood Barbara A |
SVP, Gen. Counsel, Secretary |
• – – |
2018-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,200 |
17,064 |
|
- |
|
| Wood Barbara A |
SVP, General Counsel,Secretary |
• – – |
2018-01-03 |
4 |
S |
$3.24 |
$2,249 |
D/D |
(694) |
15,864 |
|
- |
|
| Westby Keith |
SVP & COO |
• – – |
2018-01-03 |
4 |
S |
$3.24 |
$1,153 |
D/D |
(356) |
24,600 |
|
- |
|
| Guyer David R |
Executive Chairman |
• • – |
2018-01-03 |
4 |
S |
$3.24 |
$11,392 |
D/D |
(3,516) |
36,208 |
|
- |
|
| Wood Barbara A |
SVP, General Counsel,Secretary |
• – – |
2018-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,375 |
16,558 |
|
- |
|
| Westby Keith |
SVP & COO |
• – – |
2018-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
781 |
24,956 |
|
- |
|
| Guyer David R |
Executive Chairman |
• • – |
2018-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,750 |
39,724 |
|
- |
|
468 Records found
|
|
Page 9 of 19 |
|
|
